Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03861819 · ClinicalTrials.gov registry record · NA

Feasibility of VIIT in Adults With NASH

A NA study of Liver Diseases and Nonalcoholic Steatohepatitis, sponsored by Duke University.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT03861819 is a NA study of Liver Diseases and Nonalcoholic Steatohepatitis that has completed, run by Duke University. The registered enrollment target is 24 participants, below the 61,158-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03861819, a NA study of Liver Diseases and Nonalcoholic Steatohepatitis, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether patients with stage 1-3 NASH-related fibrosis are able to complete a single vigorous-intensity interval training (VIIT) session on an indoor rowing machine and provide blood samples before and afterwards. The results of this study will provide the foundation for future research on the role of VIIT in treating NASH.

Interventions

  • BEHAVIORAL Vigorous-intensity interval training (VIIT)

Study Locations (1)

North Carolina

  • Duke Integrative Medicine - Durham

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2018-01-01
Est. Completion 2018-12-07
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03861819

The ClinicalTrials.gov registry entry for NCT03861819 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61,158-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Liver Diseases appearing as the primary indexed condition, and to 1 intervention - of which Vigorous-intensity interval training (VIIT) is the first listed.

NCT03861819 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03861819 about?

NCT03861819 is a clinical study titled "Feasibility of VIIT in Adults With NASH". The purpose of this study is to determine whether patients with stage 1-3 NASH-related fibrosis are able to complete a single vigorous-intensity interval training (VIIT) session on an indoor rowing machine and provide blood samples before and afterwards. The results of this study will provide the fo...

What is the current status of trial NCT03861819?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-01-01. Estimated completion is 2018-12-07.

What conditions does trial NCT03861819 study?

This clinical trial studies the following conditions: Liver Diseases, Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis (NASH).

What interventions are being tested in trial NCT03861819?

The interventions under investigation include: Vigorous-intensity interval training (VIIT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03861819?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03861819 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Liver Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.